Oct 2 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:)
* Valeant announces pricing of private offering of senior secured notes
* Priced its previously announced offering of $1 billion aggregate principal amount of 5.500% senior secured notes due 2025